Enterprise Linux Today: SGI & Incyte Deploy Linux Bioinformatics Solution at Bristol-Myers SquibbNov 21, 2000, 22:26 (0 Talkback[s])
"SGI (NYSE: SGI) today announced the installation of a Linux-OS-based solution for bioinformatics computing at Bristol-Myers Squibb Company (NYSE: BMY), one of the world's leading diversified global health and personal care companies. Working together with Incyte Genomics, Inc. (Nasdaq: INCY), SGI Global Services delivered a bioinformatics solution that allows Bristol-Myers Squibb to increase its raw computing power, deploy new scientific applications for Linux environments and extend technology investments by increasing productivity and reducing hardware and administrative costs."
"The solution deployed at Bristol-Myers Squibb reinforces SGI's long-term commitment to life sciences, Linux and the open source community and demonstrates SGI's expertise in developing and deploying customized solutions for its customers. Bristol-Myers Squibb will use a Linux cluster from Incyte to conduct research for genomics projects, including DNA and protein sequence analysis, transcriptional profiling, and proteomics, one of the fastest growing segments of bioinformatics research."
"The SGI Origin family server sitting with a cluster of Linux machines behind it is the ideal environment for the type of computational research we conduct," said Nathan Siemers, group leader of bioinformatics at Bristol-Myers Squibb. "Some things we do take quite a bit of horsepower. The hybrid combination of Linux and SGI IRIX gives us the flexibility to do what we want, in a manner transparent to our researchers."
0 Talkback[s] (click to add your comment)